miltefosine has been researched along with wortmannin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laufer, S; Pillaiyar, T | 1 |
| Adamo, S; Coletti, D; Molinaro, M; Palleschi, S; Silvestroni, L; Tomei, F | 1 |
1 review(s) available for miltefosine and wortmannin
| Article | Year |
|---|---|
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Protein Kinase Inhibitors; SARS-CoV-2; Signal Transduction; Virus Replication | 2022 |
1 other study(ies) available for miltefosine and wortmannin
| Article | Year |
|---|---|
Surface remodeling associated with vasopressin-induced membrane traffic in L6 myogenic cells.
Topics: Acridine Orange; Acrylamide; Androstadienes; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line; Cell Membrane; Cell Movement; Cytochalasin B; Enzyme Inhibitors; Exocytosis; Fluorescent Dyes; Fluorometry; Kinetics; Ligands; Microscopy, Electron; Microscopy, Electron, Scanning; Muscles; Paclitaxel; Phosphatidylcholines; Phosphatidylinositol 3-Kinases; Phospholipids; Phosphorylcholine; Rats; Signal Transduction; Time Factors; Vasopressins; Wortmannin | 2000 |